Axon (AXON) CRO has 5,849.7 shares withheld to cover RSU taxes

Filing Impact

(Very High)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Axon Enterprise CHIEF REVENUE OFFICER Cameron Brooks reported a routine share withholding tied to equity compensation. On the transaction date, 5,849.7 shares of Common Stock were disposed of to cover tax obligations from the vesting of restricted stock units.

These shares were withheld rather than sold in the open market, reflecting a tax-withholding disposition under the company’s 2024 eXponential Stock Plan. After this event, Brooks directly held 51,695.69 shares of Axon common stock, as reported in the filing.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Brooks Cameron

Role CHIEF REVENUE OFFICER

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	5,849.7	$423.57	$2.48M

Holdings After Transaction: Common Stock — 51,695.69 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Shares withheld for taxes: 5,849.7 shares Tax withholding price: $423.57 per share Shares held after transaction: 51,695.69 shares

3 metrics

Shares withheld for taxes 5,849.7 shares Tax-withholding disposition for RSU vesting

Tax withholding price $423.57 per share Value used for 5,849.7 withheld shares

Shares held after transaction 51,695.69 shares Direct Axon common stock holdings post-event

Key Terms

restricted stock units, tax liability, withheld, Axon Enterprise, Inc. 2024 eXponential Stock Plan, +1 more

5 terms

restricted stock units financial

"arising out of the vesting of the second tranche of restricted stock units granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax liability financial

"securities withheld to settle the reporting person's tax liability arising out of the vesting"

withheld financial

"Securities disposed represent securities withheld to settle the reporting person's tax liability"

Axon Enterprise, Inc. 2024 eXponential Stock Plan financial

"granted pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan"

Compensation Committee financial

"certified by the issuer's Compensation Committee on August 28, 2025"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

Form 4 Insider Transactions: What Each Field Means →

04/02/2026 - 04:37 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brooks Cameron

(Last)

(First)

(Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE

ARIZONA

85255

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CHIEF REVENUE OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/01/2026		F⁽¹⁾		5,849.7	D	$423.57	51,695.69	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Securities disposed represent securities withheld to settle the reporting person's tax liability arising out of the vesting of the second tranche of restricted stock units granted pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions were determined to have been certified by the issuer's Compensation Committee on August 28, 2025.

Remarks:

	/s/ Cameron Brooks by Isaiah Fields, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Axon (AXON) executive Cameron Brooks report in this Form 4?

Axon CHIEF REVENUE OFFICER Cameron Brooks reported a tax-withholding disposition of 5,849.7 common shares. These shares were withheld to satisfy taxes from vesting restricted stock units, not sold in an open-market transaction, and he retained 51,695.69 shares afterward.

How many Axon (AXON) shares were withheld to cover Cameron Brooks’ taxes?

The filing shows 5,849.7 Axon common shares were withheld to settle Cameron Brooks’ tax liability. This arose from vesting of a restricted stock unit tranche under the company’s 2024 eXponential Stock Plan, according to the disclosed footnote.

At what price were Cameron Brooks’ Axon (AXON) shares valued for tax withholding?

The tax-withholding disposition used a price of $423.57 per Axon common share. This price applies to the 5,849.7 shares withheld to cover taxes linked to vesting restricted stock units granted under the company’s 2024 eXponential Stock Plan.

How many Axon (AXON) shares does Cameron Brooks hold after this transaction?

After the tax-withholding disposition, Cameron Brooks directly held 51,695.69 Axon common shares. This post-transaction balance reflects his remaining equity position as reported in the Form 4, following the withholding of 5,849.7 shares for tax obligations.

Was Cameron Brooks’ Axon (AXON) Form 4 transaction an open-market sale?

No, the Form 4 describes a tax-withholding disposition, not an open-market sale. Shares were withheld by Axon to pay taxes triggered by vesting restricted stock units, which is a standard mechanism for handling equity-related tax liabilities.

What Axon (AXON) equity plan is linked to Cameron Brooks’ tax-withholding transaction?

The shares were withheld in connection with vesting restricted stock units granted under the Axon Enterprise, Inc. 2024 eXponential Stock Plan. The footnote notes that performance conditions for this grant were certified by the company’s Compensation Committee.